Form 4: Cytek Biosciences SVP Allen Poirson Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Allen Poirson, SVP of Business and Corporate Development at Cytek Biosciences, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations on May 20, 2024.

Summary

  • On May 20, 2024, Allen Poirson, SVP of Business and Corporate Development at Cytek Biosciences, exercised restricted stock units (RSUs) and sold shares to cover tax obligations.
  • The transactions involved the vesting of 790, 1,669, and 1,252 shares of common stock through RSU awards.
  • A total of 1,447 shares were withheld by the issuer to satisfy tax obligations at a price of $5.96 per share.
  • Following these transactions, Poirson directly owns 53,669 shares of Cytek Biosciences common stock and holds 28,804 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions related to equity compensation, and it doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock; this provides transparency to the market.

Stakeholder Impact

  • The transactions have a minimal impact on shareholders as they represent a small percentage of the total outstanding shares.

Key Dates

DateDescription
May 18, 2022Initial vesting date for 4/48th of the shares underlying one RSU Award.
May 18, 2023Initial vesting date for 2/48th of the shares underlying one RSU Award.
November 30, 2023Reporting Person acquired 350 shares under the Issuer's 2021 Employee Stock Purchase Plan.
March 10, 2024Vesting date for 4/48th of the total shares underlying one RSU Award.
May 18, 2024Initial vesting date for 2/48th of the shares underlying one RSU Award.
May 20, 2024Date of stock transactions: RSU vesting and share sales for tax obligations.
May 22, 2024Date of signature for the Form 4 filing.
March 10, 2025Future vesting date for 4/48th of the total shares underlying one RSU Award.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.